Borderline Personality Disorder: Clinical Guidelines for Treatment

Area of Science:

• Psychiatry
• Genetics
• Psychology

Background:

• Borderline personality disorder (BPD) is characterized by emotional dysregulation and personality traits like anger and impulsivity.
• While schizotypal personality disorder links to schizophrenia, BPD has a less clear genetic connection to bipolar disorder.
• BPD can stem from genetic predispositions for bipolar disorder, adverse postnatal factors (e.g., abuse, incest), or a combination.

Purpose of the Study:

• To highlight the often-overlooked genetic contributions to BPD.
• To emphasize the importance of thorough family history in BPD evaluations.
• To guide treatment strategies based on genetic and environmental factors.

Main Methods:

• Review of BPD symptomatology and its relationship with other disorders.
• Emphasis on comprehensive family history assessment for mood disorders.
• Discussion of pharmacotherapy (mood stabilizers, antidepressants) and psychotherapy approaches (expressive, cognitive-behavioral).

Main Results:

• Genetic risk for bipolar disorder is a significant, yet frequently underestimated, factor in BPD.
• Early childhood ADHD and later BPD diagnosis can precede the emergence of bipolar disorder in young adulthood.
• Integrated treatment involving mood stabilizers, psychotherapy, and substance abuse programs is crucial.

Conclusions:

• Thorough family history is essential for identifying genetic links to bipolar disorder in BPD patients.
• Mood stabilizers may be more effective than antidepressants for BPD with bipolar links.
• A flexible, integrated treatment approach addressing emotional, cognitive, and substance abuse issues is vital for BPD management.